Evidence map›Paper›PMID 35216348›Full record

ReviewInternational journal of molecular sciences2022

Tunneling Nanotubes: A New Target for Nanomedicine?

Ilaria Ottonelli, Riccardo Caraffi, Giovanni Tosi, Maria Angela Vandelli, Jason Thomas Duskey, Barbara Ruozi

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Spatiotemporal HNature communications · 2025
    Article
  6. Review
  7. Editorial: The role of autophagy in cardiovascular disease.Frontiers in cell and developmental biology · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Mitochondria in health, disease, and aging.Physiological reviews · 2023
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ilaria OttonelliClinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41125 Modena, Italy.ORCID 0000-0002-2135-2422
Riccardo CaraffiNanotech Lab, Te.Far.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Giovanni TosiNanotech Lab, Te.Far.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.ORCID 0000-0001-8318-667X
Maria Angela VandelliNanotech Lab, Te.Far.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
Jason Thomas DuskeyNanotech Lab, Te.Far.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.ORCID 0000-0003-2204-1981
Barbara RuoziNanotech Lab, Te.Far.T.I., Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
University of Modena and Reggio Emilia · IT

Funding

a Ministero degli Esteri e della Cooperazione Internazionale MAECI grant, Progetti di ricerca scientifica e tecnologica di grande rilevanza by Ministero degli Esteri, Progetti Italy-USA, "Nanomedicine for Blood Brain Barrier (BBB)-crossing in CNS oncologi MAE00691612020-06-26Creutzfeldt-Jakob disease Foundation (CJDF) 01FAR Unimore Fondazione di Modena "Nano-immuno targeting per il trattamento del glioblastoma multiforme" NIT Project; GLIOSILK Project EURONANOMED2019-075IMI EU Grant "Investigating Mechanisms and Models predictive of accessibility of therapeutics (IM2PACT) Into the Brain" IMI2 - Call 12, (im2pact.org) GA n.807015Telethon project: "Pigment Epithelium-derived Factor (PEDF) peptide as therapeutic agents for inherited retinal degeneration" GGP19113
6 · The paper itself

Abstract

Tunneling nanotubes (TNTs), discovered in 2004, are thin, long protrusions between cells utilized for intercellular transfer and communication. These newly discovered structures have been demonstrated to play a crucial role in homeostasis, but also in the spreading of diseases, infections, and metastases. Gaining much interest in the medical research field, TNTs have been shown to transport nanomedicines (NMeds) between cells. NMeds have been studied thanks to their advantageous features in terms of reduced toxicity of drugs, enhanced solubility, protection of the payload, prolonged release, and more interestingly, cell-targeted delivery. Nevertheless, their transfer between cells via TNTs makes their true fate unknown. If better understood, TNTs could help control NMed delivery. In fact, TNTs can represent the possibility both to improve the biodistribution of NMeds throughout a diseased tissue by increasing their formation, or to minimize their formation to block the transfer of dangerous material. To date, few studies have investigated the interaction between NMeds and TNTs. In this work, we will explain what TNTs are and how they form and then review what has been published regarding their potential use in nanomedicine research. We will highlight possible future approaches to better exploit TNT intercellular communication in the field of nanomedicine.

Indexed as

AnimalsBiological TransportCell Membrane StructuresHumansNanomedicineNanotubesTissue DistributionTunneling Nanotubesdrug exchangenanomedicinenanoparticlestargeted therapytherapeutic efficiencytunneling nanotubes

Identifiers

PMID35216348
PMCPMC8878036
OpenAlexW4212986844

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.